RxDoctor Payments Data

Jennifer Fain, APRN

Psychiatric/Mental Health · Jacksonville, FLNPI 1710252234

Payments from drug & device makers

$1,994in general payments, 2019–2025

Across 132 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$603
  • Otsuka America Pharmaceutical, Inc.$369
  • Johnson & Johnson$330
  • AbbVie$294
  • E.r. Squibb & Sons, L.L.C.$172
  • Neurocrine Biosciences, Inc.$131
  • plus $95 from 2 others

What the payments were for

  • Food & beverage$1,994100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,994 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$7,696
Medicare patients
27
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate23$221,715
Abilify MaintenaAripiprazole35$102,807
VraylarCariprazine Hcl66$99,373
Invega SustennaPaliperidone Palmitate25$62,699
Lurasidone Hcl19$7,991
Aripiprazole96$7,160
Paliperidone ErPaliperidone24$5,237
Lisdexamfetamine Dimesylate11$2,806
Haloperidol62$2,163
Benztropine Mesylate150$1,933
Ziprasidone Hcl29$1,693
Fluphenazine Hcl33$1,660
Quetiapine Fumarate ErQuetiapine Fumarate22$1,626
Oxcarbazepine30$1,540
Hydroxyzine Hcl48$1,495

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$330$284,41448 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$369$102,80735 claims
AbbVieVraylar$294$99,37366 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →